Trkola A - Search Results

1

Trkola A. Trkola A. Nature. 2014 Oct 23;514(7523):442-3. doi: 10.1038/514442a. Nature. 2014. PMID: 25341782 No abstract available.

2

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.

Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C, Manrique A, Huber M, Rehr M, Oxenius A, Weber R, Stiegler G, Vcelar B, Katinger H, Aceto L, Günthard HF. Trkola A, et al. Nat Med. 2005 Jun;11(6):615-22. doi: 10.1038/nm1244. Epub 2005 May 8. Nat Med. 2005. PMID: 15880120 Clinical Trial.

3

Therapeutic antibodies in HIV treatment--classical approaches to novel advances.

Abela IA, Reynell L, Trkola A. Abela IA, et al. Among authors: trkola a. Curr Pharm Des. 2010;16(33):3754-66. doi: 10.2174/138161210794079245. Curr Pharm Des. 2010. PMID: 21128888 Review.

4

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies.

Rusert P, Krarup A, Magnus C, Brandenberg OF, Weber J, Ehlert AK, Regoes RR, Günthard HF, Trkola A. Rusert P, et al. Among authors: trkola a. J Exp Med. 2011 Jul 4;208(7):1419-33. doi: 10.1084/jem.20110196. Epub 2011 Jun 6. J Exp Med. 2011. PMID: 21646396 Free PMC article.

5

HIV vaccines: an attainable goal?

Reynell L, Trkola A. Reynell L, et al. Among authors: trkola a. Swiss Med Wkly. 2012 Mar 2;142:w13535. doi: 10.4414/smw.2012.13535. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22389197 Free article. Review.

6

Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Abela IA, Berlinger L, Schanz M, Reynell L, Günthard HF, Rusert P, Trkola A. Abela IA, et al. Among authors: trkola a. PLoS Pathog. 2012;8(4):e1002634. doi: 10.1371/journal.ppat.1002634. Epub 2012 Apr 5. PLoS Pathog. 2012. PMID: 22496655 Free PMC article. Clinical Trial.

7

Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.

Reh L, Magnus C, Schanz M, Weber J, Uhr T, Rusert P, Trkola A. Reh L, et al. Among authors: trkola a. PLoS Pathog. 2015 Jul 9;11(7):e1004966. doi: 10.1371/journal.ppat.1004966. eCollection 2015 Jul. PLoS Pathog. 2015. PMID: 26158270 Free PMC article.

8

HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution.

Magnus C, Reh L, Trkola A. Magnus C, et al. Among authors: trkola a. Virus Res. 2016 Jun 15;218:57-70. doi: 10.1016/j.virusres.2015.10.009. Epub 2015 Oct 19. Virus Res. 2016. PMID: 26494166 Free article.

9

The HIV-1 Entry Process: A Stoichiometric View.

Brandenberg OF, Magnus C, Regoes RR, Trkola A. Brandenberg OF, et al. Among authors: trkola a. Trends Microbiol. 2015 Dec;23(12):763-774. doi: 10.1016/j.tim.2015.09.003. Epub 2015 Nov 2. Trends Microbiol. 2015. PMID: 26541228 Review.

10

Determinants of HIV-1 broadly neutralizing antibody induction.

Rusert P, Kouyos RD, Kadelka C, Ebner H, Schanz M, Huber M, Braun DL, Hozé N, Scherrer A, Magnus C, Weber J, Uhr T, Cippa V, Thorball CW, Kuster H, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Fellay J, Regoes RR, Günthard HF, Trkola A; Swiss HIV Cohort Study. Rusert P, et al. Among authors: trkola a. Nat Med. 2016 Nov;22(11):1260-1267. doi: 10.1038/nm.4187. Epub 2016 Sep 26. Nat Med. 2016. PMID: 27668936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters